Syros Pharmaceuticals
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch SYRS and buy or sell other stocks, ETFs, and their options commission-free!About SYRS
Syros Pharmaceuticals, Inc. engages in the development of gene control therapies for cancer and diseases. Its product candidates include SY-1425, SY-2101, and SY-5609.
CEONancy A. Simonian
CEONancy A. Simonian
Employees124
Employees124
HeadquartersCambridge, Massachusetts
HeadquartersCambridge, Massachusetts
Founded2011
Founded2011
Employees124
Employees124
SYRS Key Statistics
Market cap630.05K
Market cap630.05K
Price-Earnings ratio—
Price-Earnings ratio—
Dividend yield—
Dividend yield—
Average volume5.31M
Average volume5.31M
High today$0.028
High today$0.028
Low today$0.01
Low today$0.01
Open price$0.028
Open price$0.028
Volume3.19K
Volume3.19K
52 Week high$5.22
52 Week high$5.22
52 Week low$0.01
52 Week low$0.01
People also own
Based on the portfolios of people who own SYRS. This list is generated using Robinhood data, and it’s not a recommendation.